Brief: Artivion Granted FDA Humanitarian Device Exemption For The AMDS Hybrid Prosthesis
Dec 9 (Reuters) - Artivion AORT.N :
* ARTIVION GRANTED FDA HUMANITARIAN DEVICE EXEMPTION FOR THE
AMDS
HYBRID PROSTHESIS
* ARTIVION INC: CONTINUE TO WORK TOWARDS PMA APPROVAL, WHICH
WE
STILL EXPECT IN LATE 2025
Source text: ID:nPn1Lzwzca
Further company coverage: AORT.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Artivion
See all newsUS RESEARCH ROUNDUP-Axon Enterprise, Williams-Sonoma, Xcel Energy
Artivion Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Artivion Q2 Revenue USD 125.757 Million Vs. IBES Estimate USD 120 Million
U.S. RESEARCH ROUNDUP-Applied Materials, McDonald's, McKesson
Artivion Q1 revenue slightly beats, cuts 2026 outlook